Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein

Veterinary Microbiology

Volumn 136, Issue 1-2, 2009, Pages 36-44

  Saxena, Sonal ^a   Sonwane, Arvind A ^a   Dahiya, Shyam S ^a   Patel, Chhabi Lal ^a   Saini, Mohini ^a   Rai, A ^a   Gupta, Praveen K ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Immunization; Mice; Rabies; Self replicating RNA vaccine; Sindbis

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G; RABIES VACCINE; RNA VACCINE; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; DRUG SAFETY; GEL ELECTROPHORESIS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; IMMUNOGENICITY; MOUSE; NONHUMAN; RABIES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA REPLICATION; SINDBIS VIRUS;

ANIMALS; ANTIBODIES, VIRAL; CRICETINAE; CYTOKINES; FLOW CYTOMETRY; GLYCOPROTEINS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; MICE; RABIES; RABIES VACCINES; RABIES VIRUS; SURVIVAL ANALYSIS; VACCINATION; VIRAL ENVELOPE PROTEINS;

MAMMALIA; MUS; RABIES VIRUS; SINDBIS VIRUS;

EID: 62749127010     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2008.10.030     Document Type: Article

References (49)

1. Anraku I., Harvey T.J., Linedale R., Gardner J., Harrich D., Suhrbier A., and Khromykh A.A. Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity. J. Virol. 76 (2002) 3791-3799
2. Babiuk L.A., Pontarollo R., and Babiuk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 21 (2003) 649-658
3. Beger E., Deocharan B., Edelman M., Erblich B., Gu Y., and Putterman C. A peptide DNA surrogate accelerates autoimmune manifestations and nephritis in lupus-prone mice. J. Immunol. 68 (2002) 3617-3626
4. Berglund P., Smerdou C., Fleeton M.N., Tubulekas I., and Liljestrom P. Enhancing immune responses using suicidal DNA vaccines. Nat. Biotechnol. 16 (1998) 562-565
5. Calarota S., Bratt G., and Nordlund S. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351 (1998) 1320-1325
6. Derrick S.C., Yang A.L., and Morris S.L. Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis. Infect. Immun. 73 (2005) 7727-7735
7. Dhama K., Mahendran M., Gupta P.K., and Rai A. DNA vaccines and their applications in veterinary practice: current perspectives. Vet. Res. Commun. 32 (2008) 341-356
8. Donnelly J.J., Wahren B., and Liu M.A. DNA vaccines: progress and challenges. J. Immunol. 175 (2005) 633-639
9. Fleeton M.N., Chen M., Berglund P., Rhodes G., Parker S.E., Murphy M., Atkins G.J., and Liljestrom P. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus. J. Infect. Dis. 183 (2001) 1395-1398
10. 3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis tetrazolium assays provide markedly enhanced sensitivity. J. Immunol. Methods 187 (1995) 85-93
11. Gupta P.K., Rai A., Rai N., and Saini M. Immunogenicity of a plasmid DNA vaccine encoding glycoprotein gene of rabies virus CVS in mice and dogs. J. Immunol. Immunopathol. 7 (2005) 58-61
12. Gupta P.K., Sharma S., Walunj S.S., Chaturvedi V.K., Rout A.A., Patial S., Rai A., Pandey K.D., and Saini M. Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus. Vet. Microbiol. 108 (2005) 207-214
13. Gupta P.K., Sharma S., Walunj S.S., Patil A.A., Rai A., and Saini M. DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection. Acta Virol. 50 (2006) 87-92
14. Gupta P.K., Singh R.K., Sharma R.N., Rao Y.O., and Butchaiah G. Preliminary report on a single-tube non interrupted reverse transcription polymerase chain reaction for detection of rabies virus in brain tissues. Vet. Res. Commun. 25 (2001) 239-247
15. Hariharan M.J., Driver D.A., Townsend K., Brumm D., Polo J.M., Belli B., Catton D.J., Mittelstaedt D.H., McCormack J.E., Dubensky T.W., and Karavodin L. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J. Virol. 72 (1998) 950-958
16. Herweijer H., Latendresse J.S., Williams P., Zhang G., Danko I., Schlesinger S., and Wolff J.A. A plasmid-based self-amplifying Sindbis virus vector. Hum. Gene Ther. 6 (1995) 1161-1167
17. Hoerr I., Obst R., Rammensee H.G., and Jung G. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur. J. Immunol. 30 (2000) 1-7
18. Hooper D.C. The role of immune responses in the pathogenesis of rabies. J. Neurovirol. 11 (2005) 88-92
19. Johnson P.A., Conway M.A., Daly J., Nicolson C., Robertson J., and Mills K.H. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J. Gen. Virol. 81 (2000) 1737-1745
20. Kodihalli S., Goto H., Kobasa D.L., Krauss S., Kawaoka Y., and Webster R.G. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J. Virol. 73 (1999) 2094-2098
21. Konishi E., Yamaoka M., Win K.S., Kurane I., Takada K., and Mason P.W. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus pre-membrane and envelope genes. J. Virol. 73 (1999) 5527-5534
22. Lai W.C., and Bennett M. DNA vaccines. Crit. Rev. Immunol. 18 (1998) 449-484
23. Lee J.S., Hadjipanayis A.G., and Welkos S.L. Venezualan equine Encephalitis virus-vectored vaccines protect mice against anthrax spore challenge. Infect. Immun. 71 (2003) 1491-1496
24. Leitner W.W., Hwang L.N., Bergmann-Leitner E.S., Finkelstein S.E., Frank S., and Restifo N.P. Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines. Vaccine 22 (2004) 1537-1544
25. Lodmell D.L., Ray N.B., Parnell M.J., Ewalt L.C., Hanlon C.A., and Shaddock J.H. DNA immunization protects non-human primates against rabies virus. Nat. Med. 4 (1998) 949-979
26. MacGregor R.R., Boyer J.D., Ugen K.E., Lacy K.E., Gluckman S.J., Bagarazzi M.L., Chattergoon M.A., Baine Y., Higgins T.J., Ciccarelli R.B., Coney L.R., Ginsberg R.S., and Weiner D.B. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect. Dis. 178 (1998) 92-100
27. Martin T., Parker S.E., Hedstrom R.L.T., Hoffman S.L., Norman J., Hobart P., and Lew D. Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection. Hum. Gene Ther. 10 (1999) 759-768
28. Martinon F., Krishnan S., Lenzen G., Magne R., Gomard E., Guillet J.G., Levy J.P., and Meulien P. Induction of virus specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. J. Immunol. 23 (1993) 1719-1722
29. Moore S.M., Wilkerson M.J., Davis R.D., Wyatt C.R., and Briggs D.J. Detection of cellular immunity to rabies antigens in human vaccines. J. Clin. Immunol. 26 (2006) 533-545
30. Mor G., Yamshchikov G., Sedegah M., Takeno M., Wang R., Houghten R.A., Hoffman S., and Klinman D.M. Induction of neonatal tolerance by plasmid DNA vaccination of mice. J. Clin. Invest. 98 (1996) 2700-2705
31. Morris-Downes M.M., Phenix K.V., Smyth J., Sheahan B.J., Lileqvist S., Mooney D.A., Liljestrom P., Todd D., and Atkins G.J. Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems. Vaccine 19 (2001) 1978-1988
32. Mosmann T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
33. Mossman S.P., Bex F., Berglund P., Arthos J., O'Neil S.P., Riley D., Maul D.H., Bruck C., Momin P., Burny A., Fultz P.N., Mullins J.I., Liljeström P., and Hoover E.A. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J. Virol. 70 (1996) 1953-1960
34. Nordstrom E.K.L., Forsell M.N.E., Barnfield C., Bonin E., Hanke T., Sundstrom M., Karlsson G.B., and Liljestrom P. Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1. J. Gen. Virol. 86 (2005) 349-354
35. Osorio J.E., Tomlinson C.C., Frank R.S., Haanes E.J., Rushlow K., Haynes J.R., and Stinchcomb D.T. Immunization of dogs and cats with a DNA vaccine against rabies virus. Vaccine 17 (1999) 1109-1116
36. Otten G.R., Doe B., Schaefer M., Chen M., Selby M.J., Goldbeck C., Hong M., Xu F., and Ulmer J.B. Relative potency of cellular and humoral immune responses induced by DNA vaccination. Intervirology 43 (2000) 227-232
37. Pascolo S. Vaccination with messenger RNA (mRNA). In: Bauer S., and Hartmann G. (Eds). Toll-Like Receptors (TLRs) and Innate Immunity (2008), Springer-Verlag, Berlin, Heidelberg 221-235
38. Patial S., Chatrvedi V.K., Rai A., Saini M., Chandra R., Saini Y., and Gupta P.K. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2. Vaccine 25 (2007) 4020-4028
39. Perrin P., Jacob Y., Aguilar-Setien A., Loza-Rubio E., Jallet C., Desmezieres E., Aubert M., Cliquet F., and Tordo N. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine 18 (1999) 479-486
40. Spencer L.M. Taking a bite out of rabies. J. Am. Vet. Med. Assoc. 204 (1994) 479-484
41. Tordo N., Bahloul C., Jacob Y., Jallet C., Perrin P., and Badrane H. Rabies: epidemiological tendencies and control tools. Dev. Biol. (Basel) 125 (2006) 3-13
42. 3H-thymidine incorporation assay. Vet. Immunol. Immunopathol. 70 (1999) 151-159
43. WHO, 2006. http://www.who.int/rabies.
44. Wilbur L.A., and Aubert F.A. The NIH test for potency. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), WHO, Geneva, Switzerland 360-368
45. Xiang Z.Q., Ertl H.C.J., Spitalnik S., Tran M., Wunner W.H., and Cheng J. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199 (1994) 132-140
46. Xiang Z.Q., Spitalnik S.L., Cheng J., Erikson J., Wojczyk B., and Ertl H.C.J. Immune response to nucleic acid vaccines to rabies virus. Virology 209 (1995) 569-579
47. Xiao S., Chen H., Fang L., Chuanshuang L., Zhang H., Jiang Y., and Hong W. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. Vaccine 22 (2004) 345-351
48. Xiong C., Lewis R., Shen P., Schlesinger S., Rice C.M., and Huang H.V. Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 243 (1989) 1188-1191
49. Ying H., Zaks T.Z., Wang R.F., Irvine K.R., Kammula U.S., Marincola F.M., Leitner W.W., and Restifo N.P. Cancer therapy using a self-replicating RNA vaccine. Nat. Med. 5 (1999) 823-827